Search Results - "Frank, Cathy A"

N-Aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropanamides:  KATP Potassium Channel Openers. Modifications on the Western Region by Ohnmacht, Cyrus J, Russell, Keith, Empfield, James R, Frank, Cathy A, Gibson, Keith H, Mayhugh, Daniel R, McLaren, Frances M, Shapiro, Howard S, Brown, Frederick J, Trainor, Diane A, Ceccarelli, Christopher, Lin, Margaret M, Masek, Brian B, Forst, Janet M, Harris, Robert J, Hulsizer, James M, Lewis, Joseph J, Silverman, Stuart M, Smith, Reed W, Warwick, Paul J, Kau, Sen T, Chun, Alexa L, Grant, Thomas L, Howe, Burton B, Li, Jack H, Trivedi, Shephali, Halterman, Tracy J, Yochim, Christopher, Dyroff, Martin C, Neilson, Kathleen L

Get full text

N-Aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropanamides:  KATP Potassium Channel Openers. Modifications on the Western Region by Ohnmacht, Cyrus J, Russell, Keith, Empfield, James R, Frank, Cathy A, Gibson, Keith H, Mayhugh, Daniel R, McLaren, Frances M, Shapiro, Howard S, Brown, Frederick J, Trainor, Diane A, Ceccarelli, Christopher, Lin, Margaret M, Masek, Brian B, Forst, Janet M, Harris, Robert J, Hulsizer, James M, Lewis, Joseph J, Silverman, Stuart M, Smith, Reed W, Warwick, Paul J, Kau, Sen T, Chun, Alexa L, Grant, Thomas L, Howe, Burton B, Li, Jack H, Trivedi, Shephali, Halterman, Tracy J, Yochim, Christopher, Dyroff, Martin C, Kirkland, M, Neilson, Kathleen L

“…A subset of antiandrogen compounds, the N-aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropanamides 1, were found to activate ATP sensitive potassium channels (KATP)…”
Get full text

N -Aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropanamides:  K ATP Potassium Channel Openers. Modifications on the Western Region by Ohnmacht, Cyrus J., Russell, Keith, Empfield, James R., Frank, Cathy A., Gibson, Keith H., Mayhugh, Daniel R., McLaren, Frances M., Shapiro, Howard S., Brown, Frederick J., Trainor, Diane A., Ceccarelli, Christopher, Lin, Margaret M., Masek, Brian B., Forst, Janet M., Harris, Robert J., Hulsizer, James M., Lewis, Joseph J., Silverman, Stuart M., Smith, Reed W., Warwick, Paul J., Kau, Sen T., Chun, Alexa L., Grant, Thomas L., Howe, Burton B., Li, Jack H., Trivedi, Shephali, Halterman, Tracy J., Yochim, Christopher, Dyroff, Martin C., Kirkland, M., Neilson, Kathleen L.

Get full text

N -Aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropanamides:  K ATP Potassium Channel Openers. Modifications on the Western Region by Ohnmacht, Cyrus J., Russell, Keith, Empfield, James R., Frank, Cathy A., Gibson, Keith H., Mayhugh, Daniel R., McLaren, Frances M., Shapiro, Howard S., Brown, Frederick J., Trainor, Diane A., Ceccarelli, Christopher, Lin, Margaret M., Masek, Brian B., Forst, Janet M., Harris, Robert J., Hulsizer, James M., Lewis, Joseph J., Silverman, Stuart M., Smith, Reed W., Warwick, Paul J., Kau, Sen T., Chun, Alexa L., Grant, Thomas L., Howe, Burton B., Li, Jack H., Trivedi, Shephali, Halterman, Tracy J., Yochim, Christopher, Dyroff, Martin C., M.Kirkland, and, Neilson, Kathleen L.

Get full text

Putative atypical antipsychotics with mixed dopaminergic (D 1, D 2) and serotonergic (5HT 2) activity: The design evolution of ZD3638 by Klimas, Michael T., Goldstein, Jeffrey M., Trainor, Diane A., Jacobs, Robert T., Ohnmacht, Cy J., Roberts, Richard A., Yee, Ying K., Terpko, Marc O., Thomas, Steve P., Cronk, Laura A., Frank, Cathy A., Harris, Greg D., Hulsizer, Jim, Lewis, Joe J., McLaren, Francis M., Mauger, Russ C., Morosky, Greg D., Ronkin, Steve M., Sienkewicz, Paul, Sparks, Richard B., Ulatowski, Terry G., Wildonger, Dick

“…The pharmacological activity of a series of 9,10-dihydro-9,10-methanoanthracene methylene amines which function as mixed dopaminergic (D 1/D 2) and…”
Get full text